New COVID Pill Targets High-Risk Groups | San Diego News

A new oral antiviral called Xocova just dropped, designed to prevent COVID-19 symptoms after exposure—cutting risk by 67% if taken within 3 days. Perfect for high-risk folks like the elderly or immunocompromised, but not a one-size-fits-all solution. As cases climb in places like San Diego, this could be a game-changer—but insurance approval is still pending, meaning doctors may need to fight for coverage. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/2afe783431c9e494